Zobrazeno 1 - 10
of 216
pro vyhledávání: ''
Publikováno v:
International Journal of Antimicrobial Agents. 54:824-828
Background Enterobacter spp. are a common cause of nosocomial pneumonia and treatment can be complicated by AmpC resistance. Carbapenems are the treatment of choice; however, alternatives are needed. Cefepime has been shown to be non-inferior to carb
Autor:
Christina Routsi, Eleni Antoniadou, Konstantinos Mandragos, Glykeria Vlachogianni, Eleni Belesiotou, Chronis Tasioudis, Chrisostomos Katsenos, Sofia Maraki, George Samonis, Nicky Solomonidi, Evangelos J. Giamarellos-Bourboulis, Aliki Stamou, Aikaterini Pistiki, George Dimopoulos
Publikováno v:
International Journal of Antimicrobial Agents. 54:471-477
In vitro and clinical data were analysed to evaluate the susceptibility profile of itraconazole in light of the new cut-off points. The in vitro activity of itraconazole was compared with that of eight comparators against 119 Candida bloodstream isol
Autor:
Steven Y. C. Tong, Gunter Hartel, Joshua S. Davis, Andrew Henderson, John D. Turnidge, David L. Paterson, Patrick N A Harris
Publikováno v:
International Journal of Antimicrobial Agents. 54:491-495
In clinical practice, differing opinions exists regarding the optimal management of patients with penicillin-susceptible Staphylococcus aureus (PSSA) bloodstream infection (BSI). The aim of this study was to compare the 30-day mortality of patients t
Autor:
Lindsay M. Avery, Maja Weisser, German A. Contreras, Pearlie P. Chong, Nicholas S. Britt, Cesar A. Arias, Evan J Zasowski, Michael J. Rybak, Joseph L. Kuti, Samuel L. Aitken, Adam J. DiPippo, Jann-Tay Wang, David P. Nicolau, Adrian Egli
Publikováno v:
International Journal of Antimicrobial Agents. 54:346-350
Daptomycin is commonly prescribed in combination with other antibiotics for treatment of enterococcal bacteremia. While a free drug area under the curve to minimum inhibitory concentration ( f AUC/MIC) ratio >27.4 was associated with 30-day survival
Autor:
Mandy Tallott, Jason A. Roberts, Brent Richards, Jiao Xie, Jenny Ordonez, Jeffrey Lipman, Steven C. Wallis, Gregory P Comadira, Caleb J.P. Economou
Publikováno v:
International Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents, 2019, 54, pp.351-355. ⟨10.1016/j.ijantimicag.2019.06.027⟩
International Journal of Antimicrobial Agents, 2019, 54, pp.351-355. ⟨10.1016/j.ijantimicag.2019.06.027⟩
The aim of this study was to describe the population pharmacokinetics of ticarcillin during extended daily diafiltration (EDDf) in critically ill patients with acute kidney injury. Blood samples were collected from critically ill patients prescribed
Publikováno v:
International journal of antimicrobial agents. 58(2)
Objectives The historical treatment of choice for Stenotrophomonas maltophilia infection is trimethoprim/sulfamethoxazole and this is primarily based on preclinical studies. The objective of this study was to examine the clinical outcomes of patients
Autor:
Véronique Vernet-Garnier, Hawa Cisse, Morgane Bonnet, Delphine Lebrun, Saidou Diallo, Maxime Hentzien, X. Ohl, Firouzé Bani-Sadr, Odile Bajolet
Publikováno v:
International Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents, Elsevier, 2019, 54 (2), pp.245-248. ⟨10.1016/j.ijantimicag.2019.05.010⟩
International Journal of Antimicrobial Agents, Elsevier, 2019, 54 (2), pp.245-248. ⟨10.1016/j.ijantimicag.2019.05.010⟩
Although the frequency of bone and joint infections caused by Enterobacter spp. is increasing, studies regarding the optimal antibiotic therapy are scarce. The objective of this retrospective study was to assess the clinical outcomes and safety of a
Autor:
Alejandra Duarte, Gabriela Abelenda, Joaquim Martínez-Montauti, Ana Ayestarán, Mercedes Clemente, Montserrat Sierra, Jesús Rodríguez-Baño, Jose Loureiro-Amigo, Lucía Ortega, Alejandra Morales-Cartagena, Carles Pigrau, Yolanda Meije, Nuria Fernández-Hidalgo, Alba Ribera, Xavier Sanz
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Carbapenems are considered the treatment of choice for extended-spectrum β-lactamase (ESBL)- or AmpC β-lactamase-producing Enterobacteriaceae bacteraemia. Data on the effectiveness of non-intravenous carbapenem-sparing antibiotic options are limite
Publikováno v:
International Journal of Antimicrobial Agents. 54:149-153
Ceftriaxone is an empirical antibiotic commonly used to treat pneumonia. However, its use to treat infections caused by methicillin-susceptible Staphylococcus aureus (MSSA) is controversial given limited evidence of its clinical efficacy. The objecti
Autor:
George G. Zhanel, Heather J. Adam, Nancy M. Laing, Philippe Lagacé-Wiens, Melanie R. Baxter, Andrew Walkty, James A. Karlowsky
Publikováno v:
International Journal of Antimicrobial Agents. 54:62-68
Escherichia coli isolates (n = 2035) from urine specimens of outpatients presenting to Canadian medical clinics and hospital emergency departments from 2007–2016 were collected as part of the CANWARD surveillance study. Isolate identification and a